Physician profile
Brian Cole
NPI 1861597916
$12,835.46
in general payments reported to CMS, 2019-2025
36 companies · $520 in 2025
The $520 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,919 · 2020: $1,334 · 2021: $2,356 · 2022: $3,441 · 2023: $2,660 · 2024: $606 · 2025: $520.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,252 · Travel and Lodging: $1,533.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,252.19 |
| Travel and Lodging | $1,533.28 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $4,513.42 | 2019-2023 | Aveir, Quadra Assura |
| Medtronic, INC. | $2,336.45 | 2021-2025 | Micra, Linq II |
| Astrazeneca Pharmaceuticals Lp | $1,187.86 | 2019-2023 | Farxiga |
| Novartis Pharmaceuticals Corporation | $581.53 | 2019-2023 | |
| Amgen INC. | $528.78 | 2019-2025 | Repatha, Repatha |
| Merck Sharp & Dohme LLC | $463.07 | 2021-2025 | Verquvo, Belsomra |
| Pfizer INC. | $417.18 | 2019-2023 | |
| Amarin Pharma, INC. | $342.30 | 2019-2021 | |
| Janssen Pharmaceuticals, INC | $332.90 | 2019-2020 | |
| Medicomp INC | $273.33 | 2023-2024 | Telepatch Cardiac Monitor |
| Lundbeck LLC | $244.16 | 2019-2020 | |
| Abiomed | $209.11 | 2022 | |
| Medtronic Vascular, INC. | $162.09 | 2019-2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $147.75 | 2019-2021 | |
| Shockwave Medical, INC | $133.50 | 2023 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
Show all 36 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Cole listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.